IMDX 424B5: Secondary offering
Insight Molecular Diagnostics Inc.
Filed with the SEC on · accession 0001493152-26-052499
IMDX filed a 424B5 (prospectus (offering)) with the SEC on Nov 16, 2026. Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The stock moved -13.1% by the first close after the filing.
Summary of the filing
Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The offering price, share count, and total value are not yet specified in this preliminary filing.
Key details
How IMDX stock reacted
Close before
$2.14
Nov 13, 2026
First close after
-13.08%
$1.86
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMDX?
Click hereFrequently asked questions
What did IMDX file with the SEC on Nov 16, 2026?
IMDX filed a 424B5 (Secondary offering). Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The offering price, share count, and total value are not yet specified in this preliminary filing.
What does a secondary offering mean for IMDX stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did IMDX stock react to this filing?
IMDX closed at $2.14 before the filing and $1.86 on Nov 16, 2026 (-13.08%).
Other IMDX SEC filings
- 10-Q · SEC filingNov 16, 2026
- 8-K · SEC filingNov 16, 2026
- 8-K · Material agreementSep 21, 2026
- 8-K · Fda approvalAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingJun 17, 2026
- 10-Q · SEC filingMay 13, 2026
- 8-K · SEC filingMay 13, 2026
- 8-K/A · Material agreementMay 13, 2026
- 8-K · SEC filingApr 30, 2026
Get alerts when IMDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days